These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25096497)

  • 1. Paradoxical reduction of cerebral blood flow after acetazolamide loading: a hemodynamic and metabolic study with (15)O PET.
    Watabe T; Shimosegawa E; Kato H; Isohashi K; Ishibashi M; Tatsumi M; Kitagawa K; Fujinaka T; Yoshimine T; Hatazawa J
    Neurosci Bull; 2014 Oct; 30(5):845-56. PubMed ID: 25096497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated PET/MRI scanner with oxygen-15 labeled gases for quantification of cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen.
    Ito H; Kubo H; Takahashi K; Nishijima KI; Ukon N; Nemoto A; Sugawara S; Yamakuni R; Ibaraki M; Ishii S
    Ann Nucl Med; 2021 Apr; 35(4):421-428. PubMed ID: 33502738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow and oxygen metabolism measurements using positron emission tomography on the first day after carotid artery stenting.
    Kawai N; Hatakeyama T; Okauchi M; Kawanishi M; Shindo A; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e55-64. PubMed ID: 24119366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases:
    Kobayashi M; Igarashi S; Takahashi T; Fujiwara S; Chida K; Terasaki K; Kubo Y; Ogasawara K
    Am J Nucl Med Mol Imaging; 2021; 11(6):507-518. PubMed ID: 35003888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography.
    Sette G; Baron JC; Mazoyer B; Levasseur M; Pappata S; Crouzel C
    Brain; 1989 Aug; 112 ( Pt 4)():931-51. PubMed ID: 2789086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.
    Derdeyn CP; Videen TO; Yundt KD; Fritsch SM; Carpenter DA; Grubb RL; Powers WJ
    Brain; 2002 Mar; 125(Pt 3):595-607. PubMed ID: 11872616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of deafferentation on cerebral blood flow response to acetazolamide.
    Yamauchi H; Okazawa H; Sugimoto K; Kishibe Y; Takahashi M
    AJNR Am J Neuroradiol; 2004 Jan; 25(1):92-6. PubMed ID: 14729536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
    Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K; Ogasawara K; Kuroda H; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S; Shiga T; Ishikawa T; Houkin K; Narita T; Katoh C; Tamaki N; Iwasaki Y
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
    Yamauchi H; Okazawa H; Kishibe Y; Sugimoto K; Takahashi M
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
    Hirano T; Minematsu K; Hasegawa Y; Tanaka Y; Hayashida K; Yamaguchi T
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):763-70. PubMed ID: 8063872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of cerebral revascularization.
    Leblanc R; Tyler JL; Mohr G; Meyer E; Diksic M; Yamamoto L; Taylor L; Gauthier S; Hakim A
    J Neurosurg; 1987 Apr; 66(4):529-35. PubMed ID: 3494109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day-to-day test-retest variability of CBF, CMRO2, and OEF measurements using dynamic 15O PET studies.
    Bremmer JP; van Berckel BN; Persoon S; Kappelle LJ; Lammertsma AA; Kloet R; Luurtsema G; Rijbroek A; Klijn CJ; Boellaard R
    Mol Imaging Biol; 2011 Aug; 13(4):759-68. PubMed ID: 20700768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure.
    Schumann P; Touzani O; Young AR; Morello R; Baron JC; MacKenzie ET
    Brain; 1998 Jul; 121 ( Pt 7)():1369-79. PubMed ID: 9679787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and metabolic effects of extracranial carotid disease.
    Leblanc R; Yamamoto YL; Tyler JL; Hakim A
    Can J Neurol Sci; 1989 Feb; 16(1):51-7. PubMed ID: 2784347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET measurements of CBF, OEF, and CMRO2 without arterial sampling in hyperacute ischemic stroke: method and error analysis.
    Ibaraki M; Shimosegawa E; Miura S; Takahashi K; Ito H; Kanno I; Hatazawa J
    Ann Nucl Med; 2004 Feb; 18(1):35-44. PubMed ID: 15072182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral hemodynamic evaluation using perfusion-weighted magnetic resonance imaging: comparison with positron emission tomography values in chronic occlusive carotid disease.
    Kajimoto K; Moriwaki H; Yamada N; Hayashida K; Kobayashi J; Miyashita K; Naritomi H
    Stroke; 2003 Jul; 34(7):1662-6. PubMed ID: 12791940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.